Discover 1,912 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,912
Active & Responsive
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.
for
Treponema Pallidum, Treponema Pallidum Infection,
Location: Mesquite TX, Houston TX, St. Petersburg FL,
Sponsor: American Laboratory Products Company
Sex: All
Age: 13+
Code: NCT07089836
Recruiting
Active & Responsive
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
for
Type 2 Diabetes
Location: Mesquite TX, Round Rock TX, Norman OK, Houston TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06897475
Phase2, Recruiting
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
for
Hypercholesterolemia
Location: Fort Worth TX, Dallas TX, Round Rock TX, Norman OK,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07477704
Phase2, Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
for
Glaucoma and Ocular Hypertension
Location: Fort Worth TX, Sheridan CO, Nashville TN, Peoria IL,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04967989
Phase3, Recruiting
Change in IOP Fluctuation After DSLT
for
Glaucoma
Location: Fort Worth TX
Sponsor: Ophthalmology Associates, Fort Worth
Sex: All
Age: 18+
Code: NCT07428668
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
PRECISION Pain Research Registry
for
Chronic Low Back Pain
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: All
Age: 21 - 70+
Code: NCT04853732
Recruiting
SHE Tribe: An Intervention to Improve Health Behavior Among Women in Underserved Communities
for
Health Promotion
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: Female
Age: 18+
Code: NCT03463213
Recruiting
Targeting Endoplasmic Reticulum Stress in Human Hypertension
for
Hypertension
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: All
Age: 18 - 70+
Code: NCT06025630
Phase1, Phase2, Recruiting
IHT for Mild Cognitive Impairment
for
Mild Cognitive Impairment, Memory Impairment
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: All
Age: 55 - 70+
Code: NCT05495087
Recruiting
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
for
Solid Tumours
Location: Fort Worth TX, San Antonio TX, Sioux Falls SD,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07160725
Phase1, Phase2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Fort Worth TX, Round Rock TX, Shreveport LA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase3, Recruiting
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Fort Worth TX, Dallas TX, Houston TX, Kansas City MO,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06467357
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
for
CKD, Metabolic Acidosis
Location: Fort Worth TX, Houston TX, San Antonio TX,
Sponsor: Renibus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07355062
Phase3, Recruiting
WRAP North America
for
Venous Stenosis, Venous Occlusion
Location: Fort Worth TX, Humble TX, Dothan AL, Lexington KY,
Sponsor: Merit Medical Systems, Inc.
Sex: All
Age: 18+
Code: NCT06807099
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Fort Worth TX, Mansfield TX, Dallas TX,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase3, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Fort Worth TX, Kingwood TX, Houston TX, Odessa TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Fort Worth TX, Irving TX, Palestine TX, Round Rock TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase3, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Fort Worth TX, Austin TX, Shreveport LA, San Antonio TX,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: Fort Worth TX, San Antonio TX, Westwood KS,
Sponsor: Corcept Therapeutics
Sex: All
Age: 18+
Code: NCT07259317
Phase2, Recruiting
Obalon Navigation/Touch System Post-Approval Study